FDA Announces Joint Meeting of Two Advisory Committees to Discuss Drug Safety and Reproductive Health

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Bone, Reproductive, and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss recent developments in drug safety and reproductive health, as mandated by the Federal Food, Drug, and Cosmetic Act.